KOSDAQ

Suivre
Alteogen executives celebrate shareholder approval for KOSPI listing outside Korea Exchange building, with rising stock charts.
Image générée par IA

Major bio firm Alteogen seeks KOSPI listing

Rapporté par l'IA Image générée par IA

Alteogen, the top market cap company on South Korea's secondary KOSDAQ market, has decided to move to the main KOSPI bourse to secure stable funding and enhance its corporate value. Shareholders approved the proposal on Monday, with the firm aiming for a listing next year.

Korea's main bourse operator, the Korea Exchange (KRX), announced Thursday various plans to strengthen its substantive review for delisting to expedite the exit of troubled companies. The move aligns with the government's efforts to revamp the smaller, venture-heavy KOSDAQ into something resembling the Nasdaq in the United States.

Ce site utilise des cookies

Nous utilisons des cookies pour l'analyse afin d'améliorer notre site. Lisez notre politique de confidentialité pour plus d'informations.
Refuser